Betapapillomaviruses: Innocent bystanders or causes of skin cancer

Journal of Clinical Virology

Volumn 43, Issue 4, 2008, Pages 353-360

  Feltkamp, Mariet C W ^a   de Koning, Maurits N C ^b   Bavinck, Jan Nico Bouwes ^a   ter Schegget, Jan ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b DDL DIAGNOSTIC LABORATORY   (Netherlands)

Author keywords

Betapapillomavirus; Epidermis; Human papillomavirus; Squamous cell carcinoma; Transformation

Indexed keywords

PROTEIN E6; PROTEIN E7; VIRUS DNA;

ACTINIC KERATOSIS; BETAPAPILLOMAVIRUS; EPIDERMODYSPLASIA VERRUCIFORMIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SKIN CANCER; SKIN CARCINOGENESIS; SKIN CARCINOMA; ULTRAVIOLET RADIATION; VIRUS INFECTION; VIRUS REPLICATION; VIRUS TRANSFORMATION; VIRUS TRANSMISSION;

BETAPAPILLOMAVIRUS; CELL TRANSFORMATION, VIRAL; HUMANS; MODELS, BIOLOGICAL; PAPILLOMAVIRUS INFECTIONS; SKIN NEOPLASMS;

EID: 55849143636     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2008.09.009     Document Type: Review

References (91)

1. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.-U., and zur Hausen H. Classification of papillomaviruses. Virology 324 (2004) 17-27
2. DiMaio D., and Mattoon D. Mechanisms of cell transformation by papillomavirus E5 proteins. Oncogene 20 (2001) 7866-7873
3. de Vries E., van de Poll-Franse L.V., Louwman W.J., De Gruijl F.R., and Coebergh J.W. Predictions of skin cancer incidence in the Netherlands up to 2015. Br J Dermatol 152 (2005) 481-488
4. Alam M., and Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med 344 (2001) 975-983
5. Green A., Williams G., Neale R., Hart V., Leslie D., Parsons P., et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet 354 (1999) 723-729
6. Forslund O. Genetic diversity of cutaneous human papillomaviruses. J Gen Virol 88 (2007) 2662-2669
7. Bouwes Bavinck J.N., Euvrard S., Naldi L., Nindl I., Proby C.M., Neale R., et al. Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy. J Invest Dermatol 127 (2007) 1647-1656
8. Ulrich M., Maltusch A., Rowert-Huber J., Gonzalez S., Sterry W., Stockfleth E., et al. Actinic keratoses: non-invasive diagnosis for field cancerisation. Br J Dermatol 156 (2007) 13-17
9. Jablonska S., and Orth G. Epidermodysplasia verruciformis. Clin Dermatol 3 (1985) 83-96
10. Pfister H. Chapter 8: human papillomavirus and skin cancer. J Natl Cancer Inst Monogr (2003) 52-56
11. Ramoz N., Rueda L.A., Bouadjar B., Montoya L.S., Orth G., and Favre M. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 32 (2002) 579-581
12. Barr B.B., Benton E.C., McLaren K., Bunney M.H., Smith I.W., Blessing K., et al. Papillomavirus infection and skin cancer in renal allograft recipients. Lancet 2 (1989) 224-225
13. Berkhout R.J., Tieben L.M., Smits H.L., Bouwes Bavinck J.N., Vermeer B.J., and ter Schegget J. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol 33 (1995) 690-695
14. Berkhout R.J., Bouwes Bavinck J.N., and ter Schegget J. Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol 38 (2000) 2087-2096
15. de Jong-Tieben L.M., Berkhout R.J., Smits H.L., Bouwes Bavinck J.N., Vermeer B.J., Van der Woude F.J., et al. High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients. J Invest Dermatol 105 (1995) 367-371
16. Forslund O., Antonsson A., Nordin P., Stenquist B., and Hansson B.G. A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin. J Gen Virol 80 (1999) 2437-2443
17. Forslund O., Ly H., Reid C., and Higgins G. A broad spectrum of human papillomavirus types is present in the skin of Australian patients with non-melanoma skin cancers and solar keratosis. Br J Dermatol 149 (2003) 64-73
18. Meyer T., Arndt R., Nindl I., Ulrich C., Christophers E., and Stockfleth E. Association of human papillomavirus infections with cutaneous tumors in immunosuppressed patients. Transpl Int 16 (2003) 146-153
19. Pfister H., Fuchs P.G., Majewski S., Jablonska S., Pniewska I., and Malejczyk M. High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population. Arch Dermatol Res 295 (2003) 273-279
20. Shamanin V., Glover M., Rausch C., Proby C., Leigh I.M., zur Hausen H., et al. Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients. Cancer Res 54 (1994) 4610-4613
21. Shamanin V., zur H.H., Lavergne D., Proby C.M., Leigh I.M., Neumann C., et al. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst 88 (1996) 802-811
22. Boxman I.L., Berkhout R.J., Mulder L.H., Wolkers M.C., Bouwes Bavinck J.N., Vermeer B.J., et al. Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol 108 (1997) 712-715
23. Harwood C.A., Surentheran T., Sasieni P., Proby C.M., Bordea C., Leigh I.M., et al. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol 150 (2004) 949-957
24. Antonsson A., Forslund O., Ekberg H., Sterner G., and Hansson B.G. The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J Virol 74 (2000) 11636-11641
25. Antonsson A., Erfurt C., Hazard K., Holmgren V., Simon M., Kataoka A., et al. Prevalence and type spectrum of human papillomaviruses in healthy skin samples collected in three continents. J Gen Virol 84 (2003) 1881-1886
26. Weissenborn S.J., Nindl I., Purdie K., Harwood C., Proby C., Breuer J., et al. Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. J Invest Dermatol 125 (2005) 93-97
27. Andersson K., Waterboer T., Kirnbauer R., Slupetzky K., Iftner T., de Villiers E.M., et al. Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions. Cancer Epidemiol Biomarkers Prev 17 (2008) 189-195
28. Boxman I.L., Russell A., Mulder L.H., Bavinck J.N., ter Schegget J.T., and Green A. Case-control study in a subtropical Australian population to assess the relation between non-melanoma skin cancer and epidermodysplasia verruciformis human papillomavirus DNA in plucked eyebrow hairs. Int J Cancer 86 (2000) 118-121
29. Boxman I.L., Russell A., Mulder L.H., Bouwes Bavinck J.N., ter Schegget J., and Green A. Association between epidermodysplasia verruciformis-associated human papillomavirus DNA in plucked eyebrow hair and solar keratoses. J Invest Dermatol 117 (2001) 1108-1112
30. Feltkamp M.C., Broer R., di Summa F.M., Struijk L., van der Meijden E., Verlaan B.P., et al. Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer. Cancer Res 63 (2003) 2695-2700
31. Forslund O., Iftner T., Andersson K., Lindel[ouml]f B., Hradil E., Nordin P., et al. Cutaneous human papillomaviruses found in sun-exposed skin: beta-papillomavirus species 2 predominates in squamous cell carcinoma. J Infect Dis 196 (2007) 876-883
32. Karagas M.R., Nelson H.H., Sehr P., Waterboer T., Stukel T.A., Andrew A., et al. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 98 (2006) 389-395
33. Struijk L., Bouwes Bavinck J.N., Wanningen P., van der Meijden E., Westendorp R.G., ter Schegget J., et al. Presence of human papillomavirus DNA in plucked eyebrow hairs is associated with a history of cutaneous squamous cell carcinoma. J Invest Dermatol 121 (2003) 1531-1535
34. Struijk L., Hall L., van der Meijden E., Wanningen P., Bouwes Bavinck J.N., Neale R., et al. Markers of cutaneous human papillomavirus infection in individuals with tumor-free skin, actinic keratoses, and squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 15 (2006) 529-535
35. Patel A.S., Karagas M.R., Perry A.E., and Nelson H.H. Exposure profiles and human papillomavirus infection in skin cancer: an analysis of 25 genus [beta]-types in a population-based study. J Invest Dermatol (2008)
36. de Koning M.N.C., Struijk L., Bavinck J.N.B., Kleter B., ter Schegget J., Quint W.G.V., et al. Betapapillomaviruses frequently persist in the skin of healthy individuals. J Gen Virol 88 (2007) 1489-1495
37. Michael K.M., Waterboer T., Sehr P., Rother A., Reidel U., Boeing H., et al. Seroprevalence of 34 human papillomavirus types in the German general population. PLoS Pathog 4 (2008) e1000091
38. Casabonne D., Michael K.M., Waterboer T., Pawlita M., Forslund O., Burk R.D., et al. A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nested in the Oxford component of the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 121 (2007) 1862-1868
39. Favre M., Majewski S., Noszczyk B., Maienfisch F., Pura A., Orth G., et al. Antibodies to human papillomavirus type 5 are generated in epidermal repair processes. J Invest Dermatol 114 (2000) 403-407
40. Cordano P., Gillan V., Bratlie S., Bouvard V., Banks L., Tommasino M., et al. The E6E7 oncoproteins of cutaneous human papillomavirus type 38 interfere with the interferon pathway. Virology 377 (2008) 408-418
41. De Andrea M., Mondini M., Azzimonti B., Dell'Oste V., Germano S., Gaudino G., et al. Alpha- and betapapillomavirus E6/E7 genes differentially modulate pro-inflammatory gene expression. Virus Res 124 (2007) 220-225
42. Schmitt A., Rochat A., Zeltner R., Borenstein L., Barrandon Y., Wettstein F.O., et al. The primary target cells of the high-risk cottontail rabbit papillomavirus colocalize with hair follicle stem cells. J Virol 70 (1996) 1912-1922
43. You H., Liu Y., Agrawal N., Prasad C.K., Edwards J.L., Osborne A.F., et al. Multiple human papillomavirus types replicate in 3A trophoblasts. Placenta 29 (2008) 30-38
44. Rowson K.E., and Mahy B.W. Human papova (wart) virus. Bacteriol Rev 31 (1967) 110-131
45. Kohler A., Forschner T., Meyer T., Ulrich C., Gottschling M., Stockfleth E., et al. Multifocal distribution of cutaneous human papillomavirus types in hairs from different skin areas. Br J Dermatol 156 (2007) 1078-1080
46. Antonsson A., Karanfilovska S., Lindqvist P.G., and Hansson B.G. General acquisition of human papillomavirus infections of skin occurs in early infancy. J Clin Microbiol 41 (2003) 2509-2514
47. Cartlidge P. The epidermal barrier. Semin Neonatol 5 (2000) 273-280
48. Wallin K.L., Wiklund F., Angstrom T., Bergman F., Stendahl U., Wadell G., et al. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 341 (1999) 1633-1638
49. Ho G.Y., Bierman R., Beardsley L., Chang C.J., and Burk R.D. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338 (1998) 423-428
50. de Koning M., Quint W., Struijk L., Kleter B., Wanningen P., van Doorn L.J., et al. Evaluation of a novel highly sensitive, broad-spectrum PCR-reverse hybridization assay for detection and identification of beta-papillomavirus DNA. J Clin Microbiol 44 (2006) 1792-1800
51. Hazard K., Karlsson A., Andersson K., Ekberg H., Dillner J., and Forslund O. Cutaneous human papillomaviruses persist on healthy skin. J Invest Dermatol (2006)
52. Brink A.A., Lloveras B., Nindl I., Heideman D.A., Kramer D., Pol R., et al. Development of a general-primer-PCR-reverse-line-blotting system for detection of beta and gamma cutaneous human papillomaviruses. J Clin Microbiol 43 (2005) 5581-5587
53. Gheit T., Billoud G., de Koning M.N.C., Gemignani F., Forslund O., Sylla B.S., et al. Development of a sensitive and specific multiplex PCR method combined with DNA microarray primer extension to detect betapapillomavirus types. J Clin Microbiol 45 (2007) 2537-2544
54. Purdie K.J., Surentheran T., Sterling J.C., Bell L., McGregor J.M., Proby C.M., et al. Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals. J Invest Dermatol 125 (2005) 98-107
55. Hildesheim A., Herrero R., Wacholder S., Rodriguez A.C., Solomon D., Bratti M.C., et al. Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA 298 (2007) 743-753
56. Doorbar J. The papillomavirus life cycle. J Clin Virol 32 (2005) 7-15
57. Longworth M.S., and Laimins L.A. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev 68 (2004) 362-372
58. Haller K., Stubenrauch F., and Pfister H. Differentiation-dependent transcription of the epidermodysplasia verruciformis-associated human papillomavirus type 5 in benign lesions. Virology 214 (1995) 245-255
59. Nicholls P.K., Klaunberg B.A., Moore R.A., Santos E.B., Parry N.R., Gough G.W., et al. Naturally occurring, nonregressing canine oral papillomavirus infection: host immunity, virus characterization, and experimental infection. Virology 265 (1999) 365-374
60. Nafz J., Kohler A., Ohnesorge M., Nindl I., Stockfleth E., and Rosl F. Persistence of Mastomys natalensis papillomavirus in multiple organs identifies novel targets for infection. J Gen Virol 88 (2007) 2670-2678
61. Forslund O., Lindelof B., Hradil E., Nordin P., Stenquist B., Kirnbauer R., et al. High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in "Stripped" biopsies from the same tumors. J Invest Dermatol 123 (2004) 388-394
62. Dang C., Koehler A., Forschner T., Sehr P., Michael K., Pawlita M., et al. E6/E7 expression of human papillomavirus types in cutaneous squamous cell dysplasia and carcinoma in immunosuppressed organ transplant recipients. Br J Dermatol 155 (2006) 129-136
63. Ostrow R.S., Bender M., Niimura M., Seki T., Kawashima M., Pass F., et al. Human papillomavirus DNA in cutaneous primary and metastasized squamous cell carcinomas from patients with epidermodysplasia verruciformis. Proc Natl Acad Sci USA 79 (1982) 1634-1638
64. Nindl I., Koehler A., Meyer T., Forschner T., Meijer C.J., Snijders P.J., et al. Detection of human papillomavirus DNA in primary squamous cell carcinoma and metastases. Br J Dermatol 154 (2006) 797-799
65. Lippens S., Denecker G., Ovaere P., Vandenabeele P., and Declercq W. Death penalty for keratinocytes: apoptosis versus cornification. Cell Death Differ 12 (2005) 1497-1508
66. Blanpain C., and Fuchs E. Epidermal stem cells of the skin. Annu Rev Cell Dev Biol 22 (2006) 339-373
67. Munger K., Basile J.R., Duensing S., Eichten A., Gonzalez S.L., Grace M., et al. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20 (2001) 7888-7898
68. Caldeira S., Zehbe I., Accardi R., Malanchi I., Dong W., Giarre M., et al. The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties. J Virol 77 (2003) 2195-2206
69. Dong W.L., Caldeira S., Sehr P., Pawlita M., and Tommasino M. Determination of the binding affinity of different human papillomavirus E7 proteins for the tumour suppressor pRb by a plate-binding assay. J Virol Methods 98 (2001) 91-98
70. Bedard K.M., Underbrink M.P., Howie H.L., and Galloway D.A. The E6 oncoproteins from human betapapillomaviruses differentially activate telomerase through an E6AP-dependent mechanism and prolong the lifespan of primary keratinocytes. J Virol 82 (2008) 3894-3902
71. Gabet A.S., Accardi R., Bellopede A., Popp S., Boukamp P., Sylla B.S., et al. Impairment of the telomere/telomerase system and genomic instability are associated with keratinocyte immortalization induced by the skin human papillomavirus type 38. FASEB J 22 (2008) 622-632
72. Massimi P., Thomas M., Bouvard V., Ruberto I., Campo M.S., Tommasino M., et al. Comparative transforming potential of different human papillomaviruses associated with non-melanoma skin cancer. Virology February (371) (2008) 374-379
73. Mantovani F., and Banks L. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20 (2001) 7874-7887
74. Akgul B., Garcia-Escudero R., Ghali L., Pfister H.J., Fuchs P.G., Navsaria H., et al. The E7 protein of cutaneous human papillomavirus type 8 causes invasion of human keratinocytes into the dermis in organotypic cultures of skin. Cancer Res 65 (2005) 2216-2223
75. Boxman I.L., Mulder L.H., Noya F., De Waard V., Gibbs S., Broker T.R., et al. Transduction of the E6 and E7 genes of epidermodysplasia-verruciformis-associated human papillomaviruses alters human keratinocyte growth and differentiation in organotypic cultures. J Invest Dermatol 117 (2001) 1397-1404
76. Pfefferle R., Marcuzzi G.P., Akgul B., Kasper H.U., Schulze F., Haase I., et al. The human papillomavirus type 8 E2 protein induces skin tumors in transgenic mice. J Invest Dermatol 128 (2008) 2310-2315
77. Schaper I.D., Marcuzzi G.P., Weissenborn S.J., Kasper H.U., Dries V., Smyth N., et al. Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. Cancer Res 65 (2005) 1394-1400
78. Dong W., Kloz U., Accardi R., Caldeira S., Tong W.M., Wang Z.Q., et al. Skin hyperproliferation and susceptibility to chemical carcinogenesis in transgenic mice expressing E6 and E7 of human papillomavirus type 38. J Virol 79 (2005) 14899-14908
79. Michel A., Kopp-Schneider A., Zentgraf H., Gruber A.D., and de Villiers E.M. E6/E7 expression of human papillomavirus type 20 (HPV-20) and HPV-27 influences proliferation and differentiation of the skin in UV-irradiated SKH-hr1 transgenic mice. J Virol 80 (2006) 11153-11164
80. Brash D.E., Rudolph J.A., Simon J.A., Lin A., McKenna G.J., Baden H.P., et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 88 (1991) 10124-10128
81. Hall L., Struijk L., Neale R.E., and Feltkamp M.C.W. Re: Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 98 (2006) 1425-1426
82. Giampieri S., and Storey A. Repair of UV-induced thymine dimers is compromised in cells expressing the E6 protein from human papillomaviruses types 5 and 18. Br J Cancer 90 (2004) 2203-2209
83. Iftner T., Elbel M., Schopp B., Hiller T., Loizou J.I., Caldecott K.W., et al. Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1. EMBO J 21 (2002) 4741-4748
84. Jackson S., and Storey A. E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage. Oncogene 19 (2000) 592-598
85. Leverrier S., Bergamaschi D., Ghali L., Ola A., Warnes G., Akgul B., et al. Role of HPV E6 proteins in preventing UVB-induced release of pro-apoptotic factors from the mitochondria. Apoptosis 12 (2007) 549-560
86. Underbrink M.P., Howie H.L., Bedard K.M., Koop J.I., and Galloway D.A. The E6 proteins from multiple beta HPV types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation. J Virol (2008) JVI
87. Jackson S., Harwood C., Thomas M., Banks L., and Storey A. Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev 14 (2000) 3065-3073
88. Struijk L., van der Meijden E., Kazem S., ter Schegget J., de Gruijl F.R., Steenbergen R.D.M., et al. Specific betapapillomaviruses associated with squamous cell carcinoma of the skin inhibit UVB-induced apoptosis of primary human keratinocytes. J Gen Virol 89 (2008) 2303-2314
89. Accardi R., Dong W., Smet A., Cui R., Hautefeuille A., Gabet A.S., et al. Skin human papillomavirus type 38 alters p53 functions by accumulation of deltaNp73. EMBO Rep 7 (2006) 334-340
90. Dong W., Arpin C., Accardi R., Gissmann L., Sylla B.S., Marvel J., et al. Loss of p53 or p73 in human papillomavirus type 38 E6 and E7 transgenic mice partially restores the UV-activated cell cycle checkpoints. Oncogene 27 (2008) 2923-2928
91. Bouwes Bavinck J.N., and Feltkamp M.C. Milk of human kindness?-HAMLET, human papillomavirus, and warts. N Engl J Med 350 (2004) 2639-2642